Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000547294 | SCV000630583 | likely benign | Gastrointestinal stromal tumor | 2024-01-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001013590 | SCV001174198 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-03-07 | criteria provided, single submitter | clinical testing | The c.1892-5A>G intronic variant results from an A to G substitution 5 nucleotides upstream from coding exon 13 in the PDGFRA gene. This nucleotide position is not well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. Based on the available evidence, the clinical significance of this alteration remains unclear. |